share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Bhatia Sangeeta N.

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Bhatia Sangeeta N.

福泰制药 | 4:持股变动声明-董事 Bhatia Sangeeta N.
美股sec公告 ·  08/12 16:12
Moomoo AI 已提取核心信息
On August 8, 2024, Sangeeta N. Bhatia, associated with Vertex Pharmaceuticals Inc. (VRTX), completed a transaction involving the sale of 1,292 shares of common stock at a price of $466.29 per share. The transaction resulted in a total market value of $602,446.68. Prior to this sale, Bhatia exercised options to acquire the same number of shares at $152.74 each. Following the transactions, Bhatia's direct holdings in Vertex Pharmaceuticals common stock amounted to 4,435 shares. The sale was conducted as an open market or private sale, while the acquisition was due to the exercise or conversion of derivative security.
On August 8, 2024, Sangeeta N. Bhatia, associated with Vertex Pharmaceuticals Inc. (VRTX), completed a transaction involving the sale of 1,292 shares of common stock at a price of $466.29 per share. The transaction resulted in a total market value of $602,446.68. Prior to this sale, Bhatia exercised options to acquire the same number of shares at $152.74 each. Following the transactions, Bhatia's direct holdings in Vertex Pharmaceuticals common stock amounted to 4,435 shares. The sale was conducted as an open market or private sale, while the acquisition was due to the exercise or conversion of derivative security.
2024年8月8日,福泰制药(VRTX)关联人Sangeeta N. Bhatia以466.29美元/股的价格出售了1,292股普通股。该交易导致总市值为602,446.68美元。在此出售之前,Bhatia选择以每股152.74美元的价格行使认股权,以获取相同数量的股份。在交易后,Bhatia在福泰制药普通股方面的直接持股数达到了4,435股。交易是在公开市场或私人交易中进行的,而收购是由于行使或转换衍生证券而产生的。
2024年8月8日,福泰制药(VRTX)关联人Sangeeta N. Bhatia以466.29美元/股的价格出售了1,292股普通股。该交易导致总市值为602,446.68美元。在此出售之前,Bhatia选择以每股152.74美元的价格行使认股权,以获取相同数量的股份。在交易后,Bhatia在福泰制药普通股方面的直接持股数达到了4,435股。交易是在公开市场或私人交易中进行的,而收购是由于行使或转换衍生证券而产生的。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息